Danaher Corporation vs Omnicom Group
Side-by-side comparison of AI visibility scores, market position, and capabilities
Washington DC life sciences instruments (NYSE: DHR) at $23.9B FY2024 revenue; Cytiva bioprocessing, Beckman Coulter diagnostics, biopharma destocking recovery, 2025 core revenue +3% guidance competing with Thermo Fisher.
About
Danaher Corporation is a Washington, D.C.-based global science and technology company — publicly traded on the New York Stock Exchange (NYSE: DHR) as an S&P 500 Health Care component — developing, manufacturing, and marketing analytical instruments, reagents, consumables, software, and services for life sciences research, clinical diagnostics, and environmental monitoring through approximately 65,000 employees worldwide. In fiscal year 2024, Danaher reported revenues of $23.9 billion (flat year-over-year) with non-GAAP core revenue declining 1% as the biopharma sector's inventory destocking cycle continued, with Q4 2024 revenue of $6.5 billion (+2.0% reported, +1.0% core) representing an inflection toward recovery, generating $6.7 billion in operating cash flow and $5.3 billion in free cash flow. Danaher guided 2025 core revenue growth of approximately 3% — marking the expected return to growth as biopharma customers who destocked pandemic-era bioprocessing supply surpluses return to normalized purchasing. CEO Rainer Blair leads Danaher's post-spinoff strategy: in September 2023, Danaher separated its Environmental & Applied Solutions segment as Veralto Corporation (NYSE: VLTO), creating two independent public companies — Danaher (pure-play life sciences and diagnostics) and Veralto (water quality and product identification). Danaher's current portfolio centers on bioprocessing (Cytiva's bioreactors, membranes, single-use manufacturing for drug production), clinical diagnostics (Beckman Coulter chemistry and hematology analyzers, Radiometer blood gas analyzers, Cepheid molecular diagnostics), and life sciences research instruments (SCIEX mass spectrometry, Leica Microsystems microscopy).
Advertising holding company with $15.7B FY2024 revenue; $13.5B IPG merger announced Dec 2024 to create world's largest ad group; Omni AI data platform; BBDO, DDB, TBWA flagship agencies.
About
Omnicom Group is one of the world's largest holding companies for advertising, marketing, and communications services, founded in 1986 through the merger of BBDO, Doyle Dane Bernbach, and Needham Harper Worldwide, and headquartered in New York City. The company trades on NYSE (OMC) and reported $15.7 billion in revenues for FY2024, employing approximately 100,000 professionals across more than 70 countries. CEO John Wren has led Omnicom since 1997, navigating the digital transformation of advertising from traditional media to programmatic, social, and AI-driven marketing. In December 2024, Omnicom announced the planned acquisition of Interpublic Group (IPG) in an all-stock deal valued at approximately $13.5 billion, which if completed would create the world's largest advertising holding company with over $25 billion in combined revenues.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.